Antimicrobial Resistance Practice Questions

Q: Which gene is responsible for semisynthetic penicillin resistance in Methicillin-resistant Staphylococcus aureus (MRSA)?

MecA. **Explanation:** **1. Why Option A (MecA) is Correct:** The hallmark of Methicillin-resistant *Staphylococcus aureus* (MRSA) is the acquisition of the **mecA gene**. This gene is located on a mobile genetic element called the **Staphylococcal Cassette Chromosome mec (SCCmec)**. The mecA gene encodes an altered penicillin-binding protein known as **PBP2a** (or PBP2’). Unlike normal PBPs, PBP2a has a very low affinity for β-lactam antibiotics, including semisynthetic penicillins (methicillin, oxacillin, nafcillin) and most cephalosporins. This allows the bacteria to continue cell wall synthesis even in the presence of these drugs. **2. Why Other Options are Incorrect:** * **MecB & MecD:** These are rare variants primarily identified in other staphylococcal species (like *S. sciuri*) or macrococci. They are not the primary drivers of MRSA in clinical human isolates. * **MecC:** This is a divergent homolog of mecA (sharing ~70% identity). While it also causes MRSA, it is much less common than mecA and is typically associated with livestock-associated MRSA in Europe. It is often missed by traditional PCR primers designed for mecA. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Vancomycin is the gold standard for MRSA. For VRSA/VRE, consider Linezolid or Daptomycin. * **Cephalosporin Exception:** **Ceftaroline** (5th generation) is the only cephalosporin with activity against MRSA because it can bind to PBP2a. * **Screening:** Cefoxitin disk diffusion is the preferred method for detecting MRSA in the lab, as it is a better inducer of the mecA gene than oxacillin. * **Gold Standard Test:** Detection of the **mecA gene by PCR** is the definitive diagnostic method.

Q: Extended activity of beta-lactamases inactivates which of the following?

Cephalosporins - third generation. **Explanation:** The question refers to **Extended-Spectrum Beta-Lactamases (ESBLs)**. These are enzymes produced by certain bacteria (most commonly *E. coli* and *Klebsiella pneumoniae*) that mediate resistance to a wide range of beta-lactam antibiotics. **1. Why Option A is Correct:** ESBLs are a specific class of beta-lactamases that have evolved to hydrolyze and inactivate **extended-spectrum cephalosporins** (3rd generation like Ceftriaxone, Cefotaxime, and Ceftazidime) and monobactams (Aztreonam). They do not, however, affect Carbapenems or Cephamycins (like Cefoxitin). **2. Why Other Options are Incorrect:** * **Options B, C, and D (Macrolides and Quinolones):** These are non-beta-lactam antibiotics. * **Macrolides** (e.g., Azithromycin) inhibit protein synthesis by binding to the 50S ribosomal subunit. * **Quinolones** (e.g., Ciprofloxacin) inhibit DNA synthesis by targeting DNA gyrase and Topoisomerase IV. * Since beta-lactamases specifically target the **beta-lactam ring** structure, they have no enzymatic activity against these classes of drugs. Resistance to these drugs occurs via different mechanisms like efflux pumps or target site mutations. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment of Choice:** Carbapenems (e.g., Meropenem) are the drugs of choice for serious infections caused by ESBL-producing organisms. * **Inhibitor Sensitivity:** ESBLs are typically inhibited by beta-lactamase inhibitors like **Clavulanic acid**, Sulbactam, and Tazobactam. * **Detection:** In the lab, ESBL production is confirmed by the "Double Disk Approximation Test" or "Phenotypic Synergy Test." * **Gene Association:** Most ESBLs are plasmid-mediated, commonly involving the **TEM, SHV, and CTX-M** gene families.

Q: Pneumococcal resistance to penicillin G is mainly acquired by what mechanism?

Transformation. **Explanation:** **1. Why Transformation is Correct:** *Streptococcus pneumoniae* (Pneumococcus) is a naturally competent bacterium, meaning it can actively take up exogenous DNA from its environment. Resistance to Penicillin G in Pneumococci is mediated by **alterations in Penicillin-Binding Proteins (PBPs)**, specifically PBP 2b, 2x, and 1a. Instead of acquiring a plasmid, the bacteria undergo **Transformation** by taking up DNA fragments from related viridans group streptococci. This foreign DNA is integrated into the pneumococcal genome via homologous recombination, creating "mosaic genes" that encode PBPs with a low affinity for beta-lactam antibiotics. **2. Why Other Options are Incorrect:** * **Conjugation (A):** This involves direct cell-to-cell contact via a sex pilus to transfer plasmids. While common in Gram-negative rods (e.g., *E. coli*), it is not the primary mechanism for pneumococcal penicillin resistance. * **Transduction (B):** This is the transfer of genetic material via a bacteriophage (virus). While it occurs in *Staphylococcus aureus* (e.g., for penicillinase production), it is not the mechanism for PBP modification in Pneumococci. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism Summary:** Pneumococcal resistance = **Mosaic Genes** via **Transformation** → **Altered PBPs**. * **Not Beta-lactamase:** Unlike Staphylococci, Pneumococcal resistance is **NOT** due to beta-lactamase production. Therefore, adding a beta-lactamase inhibitor (like Clavulanic acid) does not overcome this resistance. * **Drug of Choice:** For highly resistant strains (MDRSP), **Vancomycin** or **Linezolid** are often utilized. * **Other Transformation Examples:** *Neisseria gonorrhoeae* and *Haemophilus influenzae* also utilize transformation for genetic diversity and resistance.

Q: Stepwise mutation for drug resistance is seen with which of the following drugs?

Penicillin. **Explanation:** Drug resistance in bacteria can develop through different patterns of mutation. The two primary patterns are the **Stepwise (Small-step) mutation** and the **Large-step mutation**. **Why Penicillin is Correct:** Penicillin follows the **Stepwise mutation pattern** (also known as the "Penicillin-type" resistance). In this process, resistance develops gradually through a series of multiple, sequential mutations. Each individual mutation only slightly increases the Minimum Inhibitory Concentration (MIC). Therefore, clinical resistance emerges slowly over a long period of exposure. This is why increasing the dosage of penicillin can sometimes overcome low-level resistance initially. **Why the Other Options are Incorrect:** * **B. Streptomycin:** This drug follows the **Large-step mutation pattern** (also known as the "Streptomycin-type" resistance). A single-step mutation in the chromosomal gene (rpsL) can result in an immediate, high level of resistance, making the drug completely ineffective rapidly. * **C. Garamycin (Gentamicin) & D. Kanamycin:** These are aminoglycosides. While they can develop chromosomal resistance, their most common mode of resistance in a clinical setting is through **extrachromosomal inheritance** (R-plasmids) via enzymes that modify the drug (e.g., acetyltransferases), rather than the classic stepwise chromosomal mutation seen with Penicillin. **High-Yield Clinical Pearls for NEET-PG:** * **Stepwise Mutation:** Seen with Penicillin, Erythromycin, and Chloramphenicol. * **Large-step Mutation:** Seen with Streptomycin, Rifampicin, and Nalidixic acid. * **Mnemonic:** "Steps are for Pens" (Stepwise = Penicillin). * **Clinical Significance:** To prevent the emergence of resistance in drugs that follow the large-step pattern (like Rifampicin in TB), they are always used in **combination therapy**.

Q: Colistin is not active against which of the following bacteria?

Serratia. **Explanation:** The correct answer is **Serratia**. This question tests the knowledge of **intrinsic resistance** to Polymyxins (Colistin and Polymyxin B). **1. Why Serratia is correct:** Colistin works by acting as a cationic detergent that disrupts the bacterial outer membrane by binding to lipopolysaccharides (LPS). Certain Gram-negative bacteria possess intrinsic (natural) resistance to Colistin, usually due to modifications in their LPS structure that prevent the drug from binding. **Serratia marcescens** is a classic example of a Gram-negative organism that is innately resistant to Colistin. **2. Why other options are incorrect:** * **Pseudomonas aeruginosa (A) and Klebsiella pneumoniae (C):** These are typical targets for Colistin. Colistin is often used as a "last-resort" drug for Multidrug-Resistant (MDR) strains of these organisms, including Carbapenem-Resistant Enterobacteriaceae (CRE). * **Burkholderia (D):** While *Burkholderia cepacia* is also intrinsically resistant to Colistin, the question asks which of the provided options is correct. In many standardized exams, if both are present, *Serratia* or *Proteus* are the most frequently tested "high-yield" examples of intrinsic resistance. (Note: *Burkholderia* is indeed resistant, but *Serratia* is the primary intended answer in this specific MCQ context). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Colistin Resistance:** " **B**e **P**repared **S**oon **M**aybe **H**elp" → ***B**urkholderia, **P**roteus, **P**rovidencia, **S**erratia, **M**organella, **H**afnia*. * **Mechanism of Action:** Disrupts the cell membrane (detergent-like action). * **Toxicity:** Nephrotoxicity and Neurotoxicity are the major side effects. * **Acquired Resistance:** Watch for the **mcr-1 gene**, which mediates plasmid-borne resistance to Colistin, a major global health concern.

Question 1

Which gene is responsible for semisynthetic penicillin resistance in Methicillin-resistant Staphylococcus aureus (MRSA)?

Accepted Answer

MecA

Answer

MecB

Answer

MecD

Answer

MecC

Question 2

Which of the following is NOT a mechanism of resistance to MRSA?

Accepted Answer

MRSA resistance is absolutely beta-lactamase independent.

Answer

Resistance is chromosomally mediated.

Answer

Produced mainly by alteration in penicillin-binding proteins (PBPs).

Answer

Intrinsic resistance is absent.

Question 3

Which of the following drug classes does not exhibit cross-reactivity with penicillin allergy?

Accepted Answer

Carbapenems

Answer

Aminoglycosides

Answer

Oxazolidinones

Answer

Lincosamides

Question 4

Which of the following drugs is used against the bacterium Pseudomonas aeruginosa?

Accepted Answer

Piperacillin-Tazobactam

Answer

Cefotaxime

Answer

Streptomycin

Answer

Cephalexin

Question 5

Extended activity of beta-lactamases inactivates which of the following?

Accepted Answer

Cephalosporins - third generation

Answer

Macrolides

Answer

Quinolones

Answer

Quinolones

Question 6

Ureaplasma is naturally resistant to which of the following antibiotics?

Accepted Answer

Cephalosporins

Answer

Erythromycin

Answer

Tetracycline

Answer

Chloramphenicol

Question 7

Pneumococcal resistance to penicillin G is mainly acquired by what mechanism?

Accepted Answer

Transformation

Answer

Conjugation

Answer

Transduction

Answer

All of the above

Question 8

What is the most commonly used method for testing antibiotic susceptibility of bacteria?

Accepted Answer

Kirby-Bauer disc diffusion method

Answer

Epsilometer test (E test)

Answer

Broth dilution method

Answer

Stoke disc diffusion method

Question 9

Stepwise mutation for drug resistance is seen with which of the following drugs?

Accepted Answer

Penicillin

Answer

Streptomycin

Answer

Garamycin

Answer

Kanamycin

Question 10

Colistin is not active against which of the following bacteria?

Accepted Answer

Serratia

Answer

Pseudomonas aeruginosa

Answer

Klebsiella pneumoniae

Answer

Burkholderia

Antimicrobial Resistance — MCQs

Antimicrobial Resistance — MCQs

On this page

Practice by Chapter

Want unlimited practice?